Sophie Françoise Mauricetti Derchain
Up to date em infecções - Adriana Bittencourt Campaner
| Artigo | Autor(es) | Referência |
|---|---|---|
| Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology. | Hampson Ian N | Viruses. 2022 Apr; 14(Apr):doi: 10.3390/v14040757. pii: 757. |
| Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination. | Tota Joseph E, Jiang Mengzhu, Ramanakumar Agnihotram V, Walter Stephen D, Kaufman Jay S, Coutlée François, Richardson Harriet, Burchell Ann N, Koushik Anita, Mayrand Marie Hélène, Villa Luisa L, Franco Eduardo L | PloS one. 2016 ; 11():e0166329. doi: 10.1371/journal.pone.0166329. pii: . |
| Genotype Distribution Change After Human Papillomavirus Vaccination in Two Autonomous Communities in Spain. | Freire-Salinas Javier, Benito Rafael, Azueta Ainara, Gil Joaquina, Mendoza Claudia, Nicolás Montserrat, García-Berbel Pilar, Algarate Sonia, Gómez-Román Javier | Frontiers in cellular and infection microbiology. 2021 ; 11():633162. doi: 10.3389/fcimb.2021.633162. pii: . |
| Harnessing the post-vaccination era: Do emerging HPV types represent a new threat? | Ponce-de-Leon Sergio, Lizano Marcela | Cell host & microbe. 2023 Nov; 31(Nov):1774-1775. doi: 10.1016/j.chom.2023.10.013. pii: S1931-3128(23)00417-1. |
| Human Papillomavirus Genotype Replacement: Still Too Early to Tell? | Man Irene, Vänskä Simopekka, Lehtinen Matti, Bogaards Johannes A | The Journal of infectious diseases. 2021 08; 224(08):481-491. doi: 10.1093/infdis/jiaa032. pii: . |
| Long-term follow-up of human papillomavirus (HPV) type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage. | Gray Penelope, Kann Hanna, Pimenoff Ville N, Adhikari Indira, Eriksson Tiina, Surcel Heljä-Marja, Vänskä Simopekka, Dillner Joakim, Faust Helena, Lehtinen Matti | International journal of cancer. 2020 Jun; doi: 10.1002/ijc.33169. pii: . |
| Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to nine years after vaccination (IV). | Gray Penelope, Luostarinen Tapio, Vänskä Simopekka, Eriksson Tiina, Lagheden Camilla, Man Irene, Palmroth Johanna, Pimenoff Ville N, Söderlund-Strand Anna, Dillner Joakim, Lehtinen Matti | International journal of cancer. 2019 Feb; doi: 10.1002/ijc.32189. pii: . |
| Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18-45 years. | Su Yingying, Zheng Tingquan, Bi Zhaofeng, Jia Xinhua, Li Yufei, Kuang Xuefeng, Yang Yuan, Chen Qi, Lin Hongyan, Huang Yue, Huang Shoujie, Qiao Youlin, Wu Ting, Zhang Jun, Xia Ningshao | Human vaccines & immunotherapeutics. 2024 Dec; 20(Dec):2334474. doi: 10.1080/21645515.2024.2334474. pii: 2334474. |
| Potential Effects of Human Papillomavirus Type Substitution, Superinfection Exclusion and Latency on the Efficacy of the Current L1 Prophylactic Vaccines. | Hampson Ian N, Oliver Anthony W, Hampson Lynne | Viruses. 2020 Dec; 13(Dec):doi: 10.3390/v13010022. pii: 22. |
| Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology. | Hampson Ian N, Oliver Anthony W | Viruses. 2024 Aug; 16(Aug):doi: 10.3390/v16081245. pii: 1245. |